Effect of Advance Care Planning to Improve Patient-centered Care of Nursing Home Residents
BEVOR
1 other identifier
interventional
5,927
1 country
4
Brief Summary
Advance Care Planning (ACP) is an approach to support individuals in understanding and sharing their values, treatment goals, and preferences regarding future medical care. This study aims to evaluate the clinical effectiveness of implementing a complex regional ACP program focussing on nursing homes and their related health care providers. For this purpose, a cluster-randomised controlled trial (cRCT) is being conducted in four study centres in Germany: Düsseldorf, Göttingen, Halle (Saale), and Munich. 44 nursing homes with 3,520 residents will be randomised into either an intervention group, receiving the ACP-intervention described below, or into a control group that will receive usual care. The complex ACP intervention comprises training of professional ACP facilitators (micro level), supporting organisational development in nursing homes and other relevant institutions (meso level), and moderating regional change management among a network of all related health care institutions and actors (macro level). Clinical outcomes will be measured in order to describe whether the intervention improved care consistency with care preferences. Data will be collected by two independent approaches: Firstly, participating nursing homes will provide anonymous data on all their long-term care residents of a defined time period, including the hospitalisation rate (primary outcome). The primary hypothesis will test whether the complex intervention reduces the rate of hospital admissions. A group comparison of all hospitalisations in the past 12 months is made 21 months after randomisation. Secondly, all residents who have given informed consent in the first three months of the study will be repeatedly surveyed until month 21 (or until they die earlier). Treatment decisions in the face of life-threatening illness that affect any of a list of pre-defined outcomes will be evaluated as to whether they were consistent with the residents' care preferences. If residents decease, patient-centered care in the last weeks of life will be evaluated by additional interviews with the next bereaved relative, and an involved nurse. Besides, bereaved relatives will be assessed for trauma, depression and anxiety. In addition, a process evaluation and a health economic evaluation are carried out according to Medical Research Council (MRC) recommendations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2020
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2020
CompletedFirst Posted
Study publicly available on registry
April 3, 2020
CompletedStudy Start
First participant enrolled
April 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2023
CompletedAugust 15, 2023
August 1, 2023
2.4 years
March 31, 2020
August 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of hospital admissions
Number of hospital admission per 100 residents
21 months
Secondary Outcomes (8)
Change of hospital days
21 months
Change in the number of residents whose preferences were (a) known and (b) followed in the face of potentially life-threatening events
21 months
Change in the number of pre-specified unwanted invasive treatments
21 months
Change in the rate of hospital as last place of care
21 months
Change in the perception of concordance
21 months
- +3 more secondary outcomes
Study Arms (2)
Advance Care Planning Program
EXPERIMENTALImplementation of a complex regional Advance Care Planning program.
Care as usual
NO INTERVENTIONInterventions
Sustainable implementation of ACP at micro- (qualification of professional ACP facilitators to lead conversations in cooperation with family physicians), meso- (qualification of relevant co-actors, organisational development of participating institutions) and macro-level (regional ACP steering group and network), ensuring that valid ACP is encouraged, facilitated, documented, known and honored. Core of the intervention is a modular 9-day-training for ACP facilitators. These will be preferably located in regional pools, serving more than one nursing home, and reimbursed, if certified, by German sickness funds based on recent legislation (§ 132g Social Code Book \[SGB\] V: 1 full-time facilitator for 400 residents). ACP conversations will be offered to all residents. Regional intervention at meso- and macro-level comprises various formats of specific ACP training and information for leadership and staff, and aims to support professional change management.
Eligibility Criteria
You may qualify if:
- all long-term care residents of the enrolled nursing homes
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Heinrich-Heine University, Duesseldorflead
- Federal Ministry of Health, Germanycollaborator
- University Hospital Goettingencollaborator
- Martin-Luther-Universität Halle-Wittenbergcollaborator
- Ludwig-Maximilians - University of Munichcollaborator
- Universitätsklinikum Hamburg-Eppendorfcollaborator
- BARMERcollaborator
- University Hospital Munichcollaborator
Study Sites (4)
Heinrich-Heine-University
Düsseldorf, Germany
University Medical Center
Göttingen, Germany
Martin Luther University
Halle, Germany
University Hospital Großhadern, LMU
Munich, Germany
Related Publications (2)
In der Schmitten J, Lex K, Mellert C, Rotharmel S, Wegscheider K, Marckmann G. Implementing an advance care planning program in German nursing homes: results of an inter-regionally controlled intervention trial. Dtsch Arztebl Int. 2014 Jan 24;111(4):50-7. doi: 10.3238/arztebl.2014.0050.
PMID: 24612497BACKGROUNDGotze K, Bausewein C, Feddersen B, Fuchs A, Hot A, Hummers E, Icks A, Kirchner A, Kleinert E, Klosterhalfen S, Kolbe H, Laag S, Langner H, Lezius S, Meyer G, Montalbo J, Nauck F, Reisinger C, Rieder N, Schildmann J, Schunk M, Stanze H, Vogel C, Wegscheider K, Zapf A, Marckmann G, In der Schmitten J; BEVOR study group. Effectiveness of a complex regional advance care planning intervention to improve care consistency with care preferences: study protocol for a multi-center, cluster-randomized controlled trial focusing on nursing home residents (BEVOR trial). Trials. 2022 Sep 12;23(1):770. doi: 10.1186/s13063-022-06576-3.
PMID: 36096948DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Eva Hummers, Professor
Department of General Practice, University Medical Center Göttingen
- PRINCIPAL INVESTIGATOR
Friedemann Nauck, Professor
Department of Palliative Medicine, University Medical Center Göttingen
- PRINCIPAL INVESTIGATOR
Gabriele Meyer, Professor
Institute of Health and Nursing Science, Martin Luther University Halle-Wittenberg
- PRINCIPAL INVESTIGATOR
Jan Schildmann, Professor
Institute of History and Ethics of Medicine, Martin Luther University Halle-Wittenberg
- PRINCIPAL INVESTIGATOR
Claudia Bausewein, Professor
Department of Palliative Medicine, University Hospital Großhadern, LMU Munich
- PRINCIPAL INVESTIGATOR
Georg Marckmann, Professor
Institute of Ethics, History and Theory of Medicine, LMU Munich
- PRINCIPAL INVESTIGATOR
Antonia Zapf, Professor
Department of Medical Biometry and Epidemiology, UKE Hamburg
- PRINCIPAL INVESTIGATOR
Henrike Kolbe
Coordination Center for Clinical Trials, Heinrich-Heine-University, Düsseldorf
- PRINCIPAL INVESTIGATOR
Andrea Icks, Professor
Department of Public Health, Heinrich-Heine-University, Düsseldorf
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- 1. Investigators will be blinded towards group allocation. There is as risk of unblinding of investigators, therefore we will determine true blinding status at follow-up. 2. Outcomes Assessors will be consequently blinded with regard to group assignment until the statistical analysis plan is finalized.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Jürgen in der Schmitten, MD, PhD, MPH
Study Record Dates
First Submitted
March 31, 2020
First Posted
April 3, 2020
Study Start
April 6, 2020
Primary Completion
August 31, 2022
Study Completion
January 31, 2023
Last Updated
August 15, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share